France· FR:63537451
OXOMEMAZINE ZENTIVA 0,33 mg/ml, sirop
A oxomemazin product containing oxomémazine, registered in France by ZENTIVA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OXOMÉMAZINE
- Manufacturer
- ZENTIVA FRANCE
- Country
- France (FR)
- ATC code
- R06AD08
- ATC class
- Oxomemazin
- Defined daily dose
- 30 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400949246816flacon(s) en verre de 150 ml avec gobelet(s) doseur(s) polypropylèneEUR 1.99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxomemazin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Bulgaria · Булзин
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/795431cf-615d-4fbf-9e12-ee8a318f6650 GET /v1/drugs/795431cf-615d-4fbf-9e12-ee8a318f6650?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63537451",
"date_amm": "2010-07-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "OXOMÉMAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "sirop",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about oxomemazin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.